Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Apply
225Ac-DOTA-Daratumumab, 111In-DOTA-Daratumumab & Daratumumab
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step